IRIS
MUCCINI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.782
AS - Asia 1.256
NA - Nord America 1.246
SA - Sud America 230
AF - Africa 59
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.187
RU - Federazione Russa 1.065
SG - Singapore 417
CN - Cina 410
IT - Italia 207
BR - Brasile 185
VN - Vietnam 124
HK - Hong Kong 123
DE - Germania 119
SE - Svezia 115
GB - Regno Unito 66
FR - Francia 63
FI - Finlandia 40
CA - Canada 34
IN - India 34
JP - Giappone 22
ZA - Sudafrica 21
PL - Polonia 20
ES - Italia 19
AT - Austria 17
AR - Argentina 15
MX - Messico 15
TR - Turchia 15
NL - Olanda 14
AU - Australia 13
IQ - Iraq 13
LT - Lituania 12
PK - Pakistan 12
BD - Bangladesh 11
AE - Emirati Arabi Uniti 10
ID - Indonesia 10
NG - Nigeria 9
PH - Filippine 9
BE - Belgio 7
EC - Ecuador 7
TN - Tunisia 7
VE - Venezuela 7
GH - Ghana 6
CH - Svizzera 5
CO - Colombia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
IR - Iran 4
PE - Perù 4
PS - Palestinian Territory 4
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KE - Kenya 3
MA - Marocco 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
AZ - Azerbaigian 2
BH - Bahrain 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
JO - Giordania 2
MZ - Mozambico 2
NP - Nepal 2
SV - El Salvador 2
TH - Thailandia 2
TZ - Tanzania 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
PA - Panama 1
RO - Romania 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
UA - Ucraina 1
Totale 4.588
Salva come PNG Salva come JPEG
Città #
Singapore 255
Ashburn 192
Moscow 192
Dallas 180
San Jose 121
Hong Kong 119
New York 97
Shanghai 91
Beijing 71
Munich 54
Ho Chi Minh City 52
Hefei 49
Lauterbourg 44
Los Angeles 40
Milan 37
Rome 34
Boardman 33
Hanoi 33
Orem 33
Helsinki 27
São Paulo 25
Denver 23
Nuremberg 23
Lawrence 22
Princeton 22
Tokyo 22
Warsaw 20
Council Bluffs 19
Houston 17
Poplar 16
Johannesburg 15
London 15
Montreal 15
Atlanta 13
Chennai 13
Frankfurt am Main 12
Washington 11
Brooklyn 10
Guangzhou 10
Manchester 9
Santa Clara 9
Seattle 9
Toronto 9
Ankara 8
Rio de Janeiro 8
Stockholm 8
Vienna 8
Boston 7
Chicago 7
Falkenstein 7
Phoenix 7
Accra 6
Baghdad 6
Barnet 6
Belo Horizonte 6
Cesano Boscone 6
Da Nang 6
Melbourne 6
New Delhi 6
Omaha 6
Sharjah 6
Shenzhen 6
Turku 6
Amsterdam 5
Brussels 5
Hangzhou 5
Lagos 5
Lahore 5
Lappeenranta 5
Mexico City 5
Quezon City 5
San Francisco 5
Vittoria 5
Karachi 4
Lima 4
Madrid 4
Monsummano Terme 4
Ottawa 4
Pune 4
Romagnano Sesia 4
St Louis 4
Sydney 4
Tashkent 4
Vauderens 4
Angera 3
Basra 3
Buenos Aires 3
Cambridge 3
Chisinau 3
City of London 3
Columbus 3
Curitiba 3
Haiphong 3
Honolulu 3
Hải Dương 3
Ibadan 3
Jakarta 3
Las Vegas 3
Marseille 3
Naples 3
Totale 2.387
Salva come PNG Salva come JPEG
Nome #
Evaluation of HIV reservoir in specific populations: people with a multi-drug resistant virus or a viral coinfection 292
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 130
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 115
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 112
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 109
Achieving virological control in pan-resistant HIV-1 infection: A case series 108
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 108
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 107
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 106
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 103
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 102
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 101
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 97
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 97
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 96
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 94
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study 93
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV 91
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection 89
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic 88
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV 85
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 84
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium 84
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? 83
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 82
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 82
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting 80
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 78
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 78
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 76
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens 75
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 74
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 74
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen 67
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents 63
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry 61
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 59
HIV Pol: does it offer therapeutic targets for HIV? 58
Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY 58
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV 57
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 54
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 54
Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: A MODAt substudy 52
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting 47
People with four-class drug-resistant HIV-1 may have low levels of intact DNA 46
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice 7
HIV cure-related research: where we stand and where we go 4
Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy 2
Improvement in high-density lipoprotein cholesterol in people with HIV who switched from a tenofovir alafenamide-containing regimen to cabotegravir plus rilpivirine 1
Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment 1
Totale 4.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/202249 0 0 0 8 1 6 4 10 8 3 2 7
2022/2023202 52 44 11 3 8 18 25 22 5 2 6 6
2023/2024428 14 16 79 30 49 71 41 38 3 16 15 56
2024/2025877 66 28 19 33 79 90 120 109 90 49 59 135
2025/20263.145 245 187 220 388 313 129 282 292 927 162 0 0
Totale 4.722